Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07494890 · ClinicalTrials.gov registry record · NA
Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment
A NA study, sponsored by University of Cincinnati.
- Recruiting
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT07494890: Recruiting NA study, sponsored by University of Cincinnati.
NCT07494890 is a NA study that is actively recruiting participants, run by University of Cincinnati. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07494890, a NA study, is actively recruiting participants, sponsored by University of Cincinnati.
- RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Walking impairment following neurologic injury can increase the energy cost of walking threefold, acting as a functional barrier to independence. The goal of this cross-sectional study is to determine the measurement properties of a novel biomechanical cost of walking measure in chronic stroke capable of pinpointing the origins of movement inefficiencies. This research aims to: 1. determine the convergent validity of biomechanical cost of walking with functional measures in relation to metabolic cost of walking, 2. determine the reliability of biomechanical cost of walking in relation to metabolic cost of walking, 3. determine the responsiveness of biomechanical cost of walking in relation to metabolic cost of walking. Individuals with walking impairment from stroke will complete three 5-minute comfortable speed treadmill walking trials. The 3rd walking trial will be against resistance to increase cost of walking. This single session study will compare the metric properties of biomechanical cost of walking in relation to metabolic cost of walking.
Primary Outcome
Energy expenditure calculated using biomechanical variables such as force and limb motion
Interventions
- BEHAVIORAL Resisted walking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2026-06-25 |
| Est. Completion | 2027-03-01 |
| Phase | NA |
What NCT07494890 shows while recruiting
NCT07494890 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Resisted walking is the first listed.
NCT07494890 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07494890 about?
NCT07494890 is a clinical study titled "Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment". Walking impairment following neurologic injury can increase the energy cost of walking threefold, acting as a functional barrier to independence. The goal of this cross-sectional study is to determine the measurement properties of a novel biomechanical cost of walking measure in chronic stroke capab...
What is the current status of trial NCT07494890?
This trial is currently recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2026-06-25. Estimated completion is 2027-03-01.
What interventions are being tested in trial NCT07494890?
The interventions under investigation include: Resisted walking (BEHAVIORAL).
Who is sponsoring clinical trial NCT07494890?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07494890's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI